Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BT.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BT.2NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-17926.1China
BT.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BT.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-19162.8US
BT.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BT.2NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-22824.1US
BT.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BT.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
BT.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BT.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BT.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BT.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BT.2ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-24908.9Japan
BT.2ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-21969.5Japan
BT.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BT.2SWuhanCoV-spk1TTGGCAAAATTCAAGACTCACTTT2433.332435424377F-23366.4Japan
BT.2SNIID WH-1 F24381R24873TCAAGACTCACTTTCTTCCAC2142.862436424384F-20966Japan
BT.2SNIID WH-1 Seq F24383R24865AAGACTCACTTTCTTCCACAG2142.862436624386F-21400.8Japan
BE.1.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BE.1.3ORF1abPasteur-ORF1ab-1ATGAGCTTAGTCCTGTTG1844.441269012707F-17837.6France
BE.1.3ORF1abPasteur-ORF1ab-2GGTAACTGGTATGATTTCG1942.111408014098F-18581.4France
BE.1.3ORF1abCN-CDC-ORF1abCCCTGTGGGTTTTACACTTAA2142.861334213362F-20516.2China
BE.1.3ORF1abYoung-ORF1abTCATTGTTAATGCCTATATTAACC2429.171415514178F-20695.4Singapore
BE.1.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-20262.1Germany
BE.1.3ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BE.1.3ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BE.1.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BE.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
BE.1.3SChan-SCCTACTAAATTAAATGATCTCTGCTTTACT30302271222741F-27219.1China
BE.1.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BE.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.3NCN-CDC-NGGGGAACTTCTCCTGCTAGAAT22502888128902F-5518.4China
BE.1.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BE.1.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BE.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.3NUS-CDC-N-3GGGAGCCTTGAATACACCAAAA2245.452868128702F-21956.6US
BE.1.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-1648.07Singapore
BE.1.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23210.7Germany
BE.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.1.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
BE.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.1.3ORF1abNIID WH-1 F501R913TTCGGATGCTCGAACTGCACC2157.14484504F-2242.74Japan
BE.1.3ORF1abNIID WH-1 F509R854CTCGAACTGCACCTCATGG1957.89492510F-3356.01Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used